Shows / Conversations in Lung Cancer Research
Conversations in Lung Cancer Research
Welcome to Conversations in Lung Cancer Research, presented by TOGA, your go-to podcast for in-depth insights into lung cancer. Tune in for conversations with leading experts, inspiring stories, and the latest updates on clinical trials. Stay informed and empowered in the fight against lung cancer.
Episodes
Conversations in Lung Cancer ResearchEGFR Update: Improving Outcomes in EGFR-Mutated Non-Small-Cell Cancer
Welcome to the Thoracic Oncology Group of Australasia Podcast series. Today Rachel Roberts-Thomson, Medical Oncologist from Queen Elizabeth Hospital in…
Conversations in Lung Cancer ResearchThe need for a National Clinical Quality Registry in Lung Cancer
The first TOGA Podcast for 2022 is about the need for a national clinical quality registry in lung cancer. A/Professor Emily Stone, the Deputy Chair of TOGA…
Conversations in Lung Cancer ResearchALK treatment considerations in NSCLC
Welcome to the Thoracic Oncology Group of Australasia Podcast series. Today Mal Itchins, Medical Oncologist from Royal North Shore Hospital discusses ALK…
Conversations in Lung Cancer ResearchStigma and Nihilism In Lung Cancer : A Call to Action
In this TOGA Podcast and in recognising Lung Cancer Awareness month 2021, Mel Moore, TOGA Education Chair and Medical Oncologist at St Vincent’s Hospital…
Conversations in Lung Cancer ResearchChallenging the Lung Cancer Stigma
In this Podcast, Briony Scott discusses the stigma often associated with a diagnosis of lung cancer with Danielle and Terri – both diagnosed with lung cancer…
Conversations in Lung Cancer ResearchThe Value of Comprehensive Genomic Profiling in Lung Cancer
Drugs that target cancer gene mutations or rearrangements have improved outcomes for patients with many different cancers, including lung cancer, melanoma, and…
Conversations in Lung Cancer ResearchInflammation And Its Impact On The Development & Treatment Of Lung Cancer
Inflammation plays an important role in pathogenesis, development and progression of lung cancer. Widespread literature exists on the prognostic impact of…
Conversations in Lung Cancer ResearchOptimising Diagnosis & Treatment Pathways For Lung Cancer Patients
Delays in diagnosis are one of the main factors associated with reduced survival rates for lung cancer patients. Clinical guidelines have been implemented in…
Conversations in Lung Cancer ResearchLong Term Survivorship: Thriving with Metastatic Lung Cancer
Welcome to the Thoracic Oncology Group of Australasia Podcast series. This TOGA Podcast focuses on thriving with lung cancer and overcoming the challenges…
Conversations in Lung Cancer ResearchWomen and Lung Cancer: The Rising Tide
Cigarette smoking is by far the greatest cause for lung cancer. But the proportion of lung cancer in patients who have never smoked before is on the rise. In…
Conversations in Lung Cancer ResearchPractical Perspectives: Shifting the Needle in Small Cell Lung Canceer
Welcome to the Thoracic Oncology Group of Australasia Podcast series. This TOGA Podcast focuses on Small Cell Lung cancer (SCLC) – a type of lung cancer with…
Conversations in Lung Cancer ResearchLung cancer screening works!
Lung cancer screening works. Earlier detection of lung cancer presents a vastly different prognosis. Stage I disease has a median 5 year survival of greater…
Conversations in Lung Cancer ResearchDreaming of Better Treatments for Mesothelioma
Australia has one of the highest incidence rates of mesothelioma in the world. Mesothelioma is a form of cancer that most often affects the thin linings of the…
Conversations in Lung Cancer ResearchLung Cancer Careers: Preceptorship Reflections
The first virtual TOGA Preceptorship enabled 38 Preceptees involving Fellows, Advanced Trainees, Nurses and Patients to come together and discuss the landmark…
Conversations in Lung Cancer ResearchCancer won't wait: A Cancer Australia Perspective
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients – a 4 week delay in diagnosis…
Conversations in Lung Cancer Research2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer
Remarkable advances in screening, diagnosing and treating lung cancer are discussed in this Podcast. Associate Professor Nick Pavlakis, Medical Oncologists…
Conversations in Lung Cancer ResearchRedefining Survival In Lung Cancer: Meet Alexandra
Lung cancer is the leading cause of cancer related deaths in Australia, and lung cancer in never smokers is still the seventh leading cause of death. Lung…
Conversations in Lung Cancer ResearchImproving Survival In Oncogene Driven Lung Cancer
Join us for a conversation with internationally recognized Medical Oncologists and researchers, Professor Ben Solomon & Associate Professor Tom John as they…